lupin

Pharma stocks gain on hopes of US tariff relief for generics

Indian pharma stocks, including Aurobindo Pharma and Lupin, surged after reports indicated the US Administration is considering excluding generic medicines…

October 9, 2025 19:46 IST

Stocks making the big moves midday: TCS, Prestige Estates, Lupin and more

Track midday stock movers like TCS, Prestige Estates, and Lupin as key earnings and project updates drive market momentum—see full…

Updated: October 9, 2025 14:30 IST

stocks to watch today, stock market news

From TCS, Tata Elxsi to Coal India, Lupin – Here are 9 stocks to watch today

Track Coal India, GR Infraprojects, Lupin, and more as key deals and expansions put these 7 stocks in focus today—explore…

October 9, 2025 06:39 IST

Motilal Oswal latest portfolio update, Motilal Oswal top stocks 2025

Motilal Oswal portfolio shakeup: Autos upgraded, Lupin in, Sun Pharma out, Swiggy joins — What’s driving the change

Motilal Oswal revamps model portfolio, upgrading autos, adding Swiggy and Lupin; discover what’s fueling these strategic moves!

October 6, 2025 11:22 IST

From banking and financial stocks to Tata Steel, Vedanta and Vodafone Idea – Here are 14 stocks to watch today

Track top stocks today as major banks, metals, pharma, and retail firms report key Q2 FY26 updates – review the…

October 6, 2025 06:36 IST

Nomura stock picks, Hindustan Unilever buy rating, Lupin news, Anant Raj, top stock recommendations

3 ‘Buy’ recommendations by Nomura, with up to 21% upside potential

Nomura suggests 3 ‘Buy’ stocks with up to 21% potential gains — discover which picks could boost your returns! Read…

September 30, 2025 13:33 IST

Drug maker Lupin on Monday said its subsidiary has inked a pact to fully acquire Amsterdam-headquartered VISUfarma BV

Lupin buys Amsterdam-based VISUfarma for Euro 190 million to boost speciality eye care portfolio

Lupin to acquire VISUfarma for €190 million, enhancing its European presence and ophthalmology portfolio with over 60 eye health products.

September 29, 2025 10:43 IST

Nifty Pharma index today, Nifty Pharma down, Indian pharma stocks fall

Pharma stocks crack, Nifty Pharma Index slips over 2% as Trump unveils 100% tariff: 3 key factors investors must watch

Nifty Pharma index drops over 2% after Trump unveils 100% tariff on drug imports – see which stocks are most…

September 26, 2025 11:50 IST

Defence stocks surge: Nifty Defence Index rockets 4% – Top movers powering the rally

The defence sector stocks are rallying in trade today. The top movers in this sector include the likes of Mazagon…

September 12, 2025 13:01 IST

KRBL share price, Vodafone Idea stock, RVNL share price, RailTel stock

Stocks making the biggest moves midday: BEL, Paras Defence, JBM Auto, and others

Stocks like BEL, Mazagon Dock, Paras Defence, JBM Auto, and Lupin surge as Indian markets rally – discover top movers…

September 12, 2025 12:59 IST

Big pharma bet: Jefferies lists out India’s next CRDMO multibaggers with up to 37% upside potential

Growth prescription: The future is specialty; Sun Pharma, Dr Reddy’s, Cipla lead, says Nomura

Nomura’s June 2025 analysis shows Indian pharma majors like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus posting strong specialty…

August 11, 2025 16:58 IST

3 ‘Buy’ recommendation by Nomura, with up to 60% upside

Nomura suggests ‘Buy’ on EPL, Lupin, and Britannia, seeing up to 60% upside – explore what drives these picks now!

August 8, 2025 06:02 IST

Stocks making biggest midday moves: Tata Motors, Ola Electric, Bharat Dynamics and more

Stocks making the biggest moves midday: NSDL, BHEL, Lupin and more

See which stocks like NSDL and BHEL are making big moves amid market volatility – discover the latest midday trading…

August 7, 2025 14:25 IST

Nifty 50, Nifty Pharma Index, Nifty Realty Index, IT stocks, FMCG stocks

From Bharti Airtel, Lupin to NSDL, 8 stocks to watch today

Track top stocks like Bharti Airtel, Lupin, and NSDL today as earnings and key IPOs drive market action-see which stocks…

August 6, 2025 06:44 IST

Trump tariff on India, pharma sector impact, Indian pharma exports

Trump tariff impact on Pharma: Breathing easy or trapped in crosshair ahead? Here’s how stocks are reacting

Trump’s new tariffs spark uncertainty for India’s pharma exports and stocks; check out how the sector is reacting and what…

July 31, 2025 10:59 IST

Lupin signs $50 million biosimilar licensing deal with Zentiva

Lupin inks $50 million licensing deal with Zentiva for global biosimilar rollout

Lupin has signed a $50 million licensing deal with Zentiva for the global commercialization of its biosimilar Certolizumab Pegol, targeting…

July 9, 2025 11:00 IST

GIFT Nifty, Sensex, Nifty, stock market opening, Asian markets, US markets

From Tata Steel, IndusInd Bank to BEML – Here are 10 stocks to watch

Stocks in Focus: Discover today’s top 10 stocks in focus, key Q1 earnings, and major corporate actions – explore the…

July 7, 2025 06:40 IST

Lupin to Spin Off Consumer Healthcare Business, LupinLife, to Boost Growth in India's Self-Care Market. (Image Source: Canva)

Lupin spins off consumer healthcare business

Pharmaceutical major Lupin Limited has announced the strategic spin-off of its consumer healthcare business, LupinLife Consumer Healthcare Ltd. (LCH), into…

July 2, 2025 09:48 IST

Related News

Aadhaar Card update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

Smart Investor’s Guide to Safe Investing Online

5 Red Flags Every Investor Should Watch Out For

Finfluencers and Your Money: Who Can You Trust?

gold price fall, gold price jump, gold rate today, gold returns yearly, gold bull run

Govt’s gold bond debt hits Rs 1.5 trillion

ECL may trigger higher provisions, but banks seen resilient

Business1 hr ago

Analysts predict near-term pressure for lenders with high exposure to MSMEs or unsecured segment due to draft ECL framework. Private banks well-positioned, while public sector banks may see limited impact. RBI gives 5-year transition period, with higher provisions for credit-impaired loans. Cooling-off period may delay upgrades and recoveries.

View all shorts